Aurobindo Pharma reports consolidated Q3 net loss of Rs 28.54 crore

14 Feb 2012 Evaluate

Drug firm, Aurobindo Pharma has reported consolidated net loss of Rs 28.54 crore for the quarter ended December 31, 2011, against net profit of Rs 188.63 crore for the corresponding period last fiscal. The group’s consolidated net sales rose by 7.74% to Rs 1,284.51 crore during the quarter under review from Rs 1,192.20 crore in the year-ago period.

On a standalone basis, the company posted a net profit of Rs 12.93 crore for the third quarter ended December 31, 2011, as against Rs 183.85 crore in the same period last fiscal. Net sales rose by 3.88% to Rs 1,201.50 crore during the quarter under review from Rs 1,156.61 crore in the year-ago period.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×